Literature DB >> 5486638

Cortical hyperostosis with hyperphosphatemia: a new syndrome?

R E Melhem, S S Najjar, A K Khachadurian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5486638     DOI: 10.1016/s0022-3476(70)80081-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors:  A Metzker; B Eisenstein; J Oren; R Samuel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

2.  Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders.

Authors:  Yaacov Frishberg; Orit Topaz; Reuven Bergman; Doron Behar; Drora Fisher; Derek Gordon; Gabriele Richard; Eli Sprecher
Journal:  J Mol Med (Berl)       Date:  2004-12-15       Impact factor: 4.599

3.  Calcinosis cutis, osteoma cutis, poikiloderma and skeletal abnormalities (COPS syndrome)--a new entity?

Authors:  A P Oranje; S M de Muinck Keizer-Schrama; V D Vuzevski; M Meradji
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

4.  Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.

Authors:  Hasan Otukesh; Rozita Hoseini; Hamid Chalian; Majid Chalian; Amir Ebrahim Safarzadeh; Marjan Shakiba; Ali Poorian
Journal:  Pediatr Nephrol       Date:  2007-04-17       Impact factor: 3.714

5.  Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.

Authors:  Eli Sprecher
Journal:  J Invest Dermatol       Date:  2009-10-29       Impact factor: 8.551

Review 6.  Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.

Authors:  Ilana Chefetz; Eli Sprecher
Journal:  Biochim Biophys Acta       Date:  2008-10-25

Review 7.  Insights from genetic disorders of phosphate homeostasis.

Authors:  Marta Christov; Harald Jüppner
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.